EUVIMEDEUVIMED entdecken
Crossref

Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway

Qi Fang iD, Xiaojun Zhang, Chong-Bo Ma, Quanyi Liu, Jingyuan Yu iD, Jiaqi Li iD, Hao Sun, Jicheng Ma, Hui Wei iD, Yan Du iD

ACS Nano · 2026

DOI: 10.1021/acsnano.6c12630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Qi Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, National & Local United Engineering Laboratory for Power…. Hauptthemen laut MEDLINE: Oxidative Stress, Doxorubicin, Proto-Oncogene Proteins c-akt, Antineoplastic Agents. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China, CAS-SAFEA International Partnership Program for Creative Research Teams.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance and dose-limiting toxicity remain major challenges in cancer chemotherapy, largely driven by aberrant activation of the protein kinase B (AKT) survival pathway. Although small-molecule AKT inhibitors can enhance chemosensitivity, their systemic activity frequently disrupts normal metabolic processes and causes severe side effects. Here, we report an “all-in-one” catalytic nanodrug that integrates a dual-enzyme-mimicking nanozyme (GPMM) with doxorubicin (Dox) to overcome these limitations. GPMM simultaneously exhibits peroxidase (POD)-like and phosphatase-like activities, enabling two synergistic biochemical actions: (i) amplification of reactive oxygen species (ROS) through tumor-microenvironment-responsive catalytic conversion of endogenous hydrogen peroxide (H2O2), and (ii) depletion of intracellular nicotinamide adenine dinucleotide (NADH) to weaken antioxidant defenses. This dual modulation induces persistent oxidative stress and leads to precise inhibition of AKT phosphorylation, functioning as an effective and safer alternative to conventional AKT inhibitors. As a result, Dox@GPMM markedly enhances chemosensitivity and suppresses tumor growth in nonresistant MCF-7 breast cancer models, while the MUC1 aptamer-functionalized formulation AP-Dox@GPMM effectively reverses Dox resistance in MCF-7-ADR models, without observable systemic toxicity. RNA-sequencing analysis further reveals that the nanozyme regulates key genes involved in metabolism, survival, and AKT-related signaling, thereby reshaping cellular response to chemotherapy. Collectively, this nanozyme-driven redox strategy provides a robust and generalizable approach for boosting chemotherapeutic efficacy while minimizing adverse effects, offering strong translational potential for overcoming resistance across diverse tumor types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressDoxorubicinProto-Oncogene Proteins c-aktAntineoplastic AgentsNanoparticlesHumansAnimalsMCF-7 CellsSignal TransductionMiceReactive Oxygen Species

Stichwörter der Autor:innen

chemosensitivitydrug resistancenanozymeoxidative stressprotein kinase B (AKT) pathwaysynergistic treatment

Substanzen

DoxorubicinProto-Oncogene Proteins c-aktAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, National & Local United Engineering Laboratory for Power Batteries, Key Laboratory of Nanobiosensing and Nanobioanalysis at Un…
  • State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui230026, China.
  • Department of Physical and Chemical Inspection, Nanguan District Center for Disease Control and Prevention, Changchun, Jilin130042, China.
  • School of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing, Jian…

ORCID-Profile: Qi Fang, Jingyuan Yu, Jiaqi Li, Hui Wei, Yan Du

Förderung

  • Natural Science Foundation of Jilin Province
  • National Natural Science Foundation of China
  • CAS-SAFEA International Partnership Program for Creative Research Teams
  • Fundamental Research Funds for the Central Universities
  • Jilin Provincial Scientific and Technological Development Program
  • Capital Construction Fund Projects within the Budget of Jilin Province
  • Major Project of Changchun State Key Laboratory
  • Cooperation Funding of Changchun with Chinese Academy of Sciences

Zitieren

APA

Fang, Q., Zhang, X., Ma, C. B., Liu, Q., Yu, J., Li, J., Sun, H., Ma, J., Wei, H., & Du, Y. (2026). Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway. ACS Nano. https://doi.org/10.1021/acsnano.6c12630

Vancouver

Fang Q, Zhang X, Ma CB, Liu Q, Yu J, Li J, et al. Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway. ACS Nano. 2026. doi:10.1021/acsnano.6c12630

BibTeX
@article{Fang2026,
  author = {Fang, Qi and Zhang, Xiaojun and Ma, Chong-Bo and Liu, Quanyi and Yu, Jingyuan and Li, Jiaqi and Sun, Hao and Ma, Jicheng and Wei, Hui and Du, Yan},
  title = {Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c12630}
}
Kostenlos starten →